OvaScience (OVAS) Stock Price, News & Analysis

Company Overview

Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.

Key Stats

• Today's Range: $0.90 to $0.94
• 50-Day Range: $8.56 to $17.10
• 52-Week Range: $0.66 to $1.52
• Volume: 833,144 shs
• Average Volume: 163,131 shs
• Market Capitalization: $32.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OVAS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of OvaScience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OvaScience investors own include Synergy Pharmaceuticals (SGYP), OPKO Health (OPK), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Melinta Therapeutics (MLNT), TherapeuticsMD (TXMD) and Bed Bath & Beyond (BBBY).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:OVAS
• CUSIP: N/A
• CIK: 1544227
• Web: www.ovascience.com
• Phone: (734) 845-9000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-50,970,000.00
• Net Margins: -10,128.37%
• Pretax Margin: N/A
• Return on Equity: -47.06%
• Return on Assets: -42.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 12.62
• Quick Ratio: 12.62

Sales & Book Value

• Annual Sales: $290,000.00
• Price / Sales: 113.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.80 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 35,830,000
• Free Float: N/A
• Market Cap: $33.05 million
• Optionable: Not Optionable
• Beta: 3.11